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The mammalian genome is packed tightly in the nucleus of the cell. This packing is primar-
ily facilitated by histone proteins and results in an ordered organization of the genome in
chromosome territories that can be roughly divided in heterochromatic and euchromatic
domains. On top of this organization several distinct gene regulatory elements on the
same chromosome or other chromosomes are thought to dynamically communicate via
chromatin looping. Advances in genome-wide technologies have revealed the existence of
a plethora of these regulatory elements in various eukaryotic genomes. These regulatory
elements are deﬁned by particular in vitro assays as promoters, enhancers, insulators, and
boundary elements. However, recent studies indicate that the in vivo distinction between
these elements is often less strict. Regulatory elements are bound by a mixture of com-
mon and lineage-speciﬁc transcription factors which mediate the long-range interactions
between these elements. Inappropriate modulation of the binding of these transcription
factors can alter the interactions between regulatory elements, which in turn leads to
aberrant gene expression with disease as an ultimate consequence. Here we discuss the
bi-modal behavior of regulatory elements that act in cis (with a focus on enhancers), how
their activity is modulated by transcription factor binding and the effect this has on gene
regulation.
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INTRODUCTION
Expression of genes is to a large extent directed by regulatory
sequences within the promoters of genes. However, early trans-
fection experiments led to the realization that promoters alone
were not enough to direct the proper expression of genes. The ﬁrst
enhancers described were SV40 viral repeat sequences that are able
to boost expression of a rabbit β-globin construct (Banerji et al.,
1981). This enhancement of expression occurred independent of
the orientation and location of the enhancer sequence within the
reporter construct and this observation became the operational
deﬁnition of enhancer elements. Soon after the description of
viral enhancer sequences the ﬁrst mammalian enhancer sequences
were discovered within the human immunoglobulin heavy Chain
locus (Banerji et al., 1983) and it turned out that this enhancer
sequence acts in a tissue-speciﬁc fashion. Since the ﬁrst enhancer
discovery in humans, many more enhancers have been discov-
ered in different organisms and it is estimated that over 1 million
enhancers reside in the human genome (Heintzman et al., 2009).
It is also becoming clear that enhancers are marked by the bind-
ing of speciﬁc chromatin modiﬁcation factors and the presence
of speciﬁc histone modiﬁcations (Maston et al., 2012). Recent
work also suggests that not only protein-coding genes are under
the inﬂuence of enhancers but that microRNA genes might also
be under long-range developmental control (Sheng and Previti,
2011). Although we have come a long way in the 30 years since the
ﬁrst discovery of enhancers, their discovery still remains a chal-
lenging task and the mechanism of enhancer action is still largely
unknown.
ENHANCER DISCOVERY BY MAPPING TRANSCRIPTION
FACTOR BINDING SITES AND CHROMATIN MODIFICATIONS
Discovery of enhancers has always been a formidable task. DNAseI
hypersensitivity mapping was the method of choice since it was
observed that regulatory regions within the genome are hyper-
sensitive to DNAseI digestion (Wu, 1980). However, this method
was tedious, requiring careful titration of DNAseI concentration,
restrictiondigestion, Southernblotting, anddetectionwith labeled
nucleotide probes which yielded only information on particular
sequences or loci. The ﬁrst attempts to identify enhancers on
a genome-wide scale did not depend on DNaseI but involved
enhancers traps (Hamada, 1986). In this method, a selectable
reporter gene driven by an enhancer dependent promoter is ran-
domly integrated in to the genome. Clones in which the reporter
gene has integrated within the vicinity of an enhancer can be
selected and the enhancer sequences isolated. Subsequent vali-
dation of enhancer activity can be done in vitro by transiently
transfecting luciferase reporter constructs in cell lines or in vivo
using reporter constructs in transgenic animals. However, this
method remains a laborious procedure.
With the emergence of complete sequence information from
many different model organisms attempts were made to iden-
tify regulatory sequences based on sequence conservation. These
bioinformatics attempts were moderately successful (Meireles-
Filho and Stark, 2009). However, it has become clear that not
all conserved non-coding sequences have a detectable (enhancer)
activity and not all enhancers are conserved at the sequence
level (Blow et al., 2010; Royo et al., 2011). Recent advances
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in genome-wide technologies like array technology and more
recently high-throughput sequencing are proving to be a game
changer for the genome-wide discovery of enhancers. More tra-
ditional techniques are currently combined with high-throughput
sequencing technologies to identify enhancers on a genome-wide
scale and novel approaches of enhancer discovery are introduced.
One of the ﬁrst techniques to be combined with array tech-
nology and later high-throughput sequencing as a read out was
chromatin immunoprecipitation (ChIP; Barski et al., 2007; John-
son et al., 2007; Mikkelsen et al., 2007; Robertson et al., 2007)
and even “old school” DNAseI hypersensitive site mapping has
been combined with high-throughput sequencing in order to
obtain genome-wide maps of “open” chromatin associated with
regulatory regions (Sabo et al., 2006; Hesselberth et al., 2009;
Bernstein et al., 2010).
Early genome-wide ChIP experiments found that enhancers
are enriched in speciﬁc chromatin marks, especially high levels of
H3K4me1 in combination with low levels of H3K4me3 appeared
to mark enhancer sequences (Heintzman et al., 2007). Later it
was found that acetylation of histone H3 at lysine 27 (H3K27Ac)
speciﬁcally marks active enhancers (Creyghton et al., 2010) and
recently it has been reported that in T-lymphocytes di- and tri-
methylation of histoneH3 at lysine 4 are also correlatedwith active
enhancers (Pekowska et al., 2011). Asmanymore chromatinmod-
iﬁcations have recently been identiﬁed (Tan et al., 2011), it is to be
expected that several of these novel chromatin marks associate
with enhancers (Kellner et al., 2012). Transcriptional co-activators
like the acetyltransferase and transcriptional co-activator p300
(Visel et al., 2009a; May et al., 2011), the ATAC histone acetyl
transferase complex (Krebs et al., 2011) and the ATP-dependent
chromatin remodeler CHD7 (Schnetz et al., 2009, 2010) also
appear to locate at enhancers. Clusters of tissue-speciﬁc transcrip-
tion factors are hallmarks of enhancers and this fact has been
exploited to identify enhancers. He et al. (2011) used a set of ﬁve
cardiac-speciﬁc transcription factors to identify cardiac-speciﬁc
enhancers that were distinct from p300 bound enhancers. Analysis
of the binding of a set of threemyogenic-speciﬁc transcription fac-
tors in combination with p300 binding and enhancer-associated
chromatin marks before and after muscle differentiation allowed
for the identiﬁcation of muscle-speciﬁc enhancers (McCord et al.,
2011). Furthermore, themysterious highly occupied target (HOT)
regions which are bound by many transcription factors but lack
their consensus binding motif, function as spatial and tempo-
ral enhancers in transgenic assays (Kvon et al., 2012). Conversely,
mapping of tissue-restricted enhancers via chromatin marks has
lead to the discovery of speciﬁc transcription factor binding
signatures that correspond to monocyte differentiation states
(Pham et al., 2012).
Several laboratories have deﬁned distinct chromatin signatures
associated with speciﬁc regulatory elements based on the combi-
natorial analysis of multiple chromatin marks and transcription
factor binding patterns (Wang et al., 2008; Ram et al., 2011; Bonn
et al., 2012; Cotney et al., 2012; Hoffman et al., 2012), which allows
to distinguish between speciﬁc enhancer states (Rada-Iglesias et al.,
2011; Zentner et al., 2011; Bogdanovic et al., 2012; Cotney et al.,
2012). Novel approaches to detect regulatory genomic regions are
also emerging like formaldehyde-assisted isolation of regulatory
elements (FAIRE) which identiﬁes the more “open” chromatin
state associated with enhancers based on differences in phenol
extractability of these regions (Giresi et al., 2007). Analysis of dif-
ferent genome-wide data sets is also revealing novel properties of
enhancers. Global nuclear run-on followed by high-throughput
sequencing (GRO-seq) data revealed that enhancers display bidi-
rectional expression of short transcripts (Melgar et al., 2011;Wang
et al., 2011), while an in depth analysis of glucocorticoid recep-
tor (GR)-regulated enhancers revealed that they are enriched
in CpG dinucleotides and that their methylation status is cell
type-speciﬁc and correlate with the accessibility of the enhancers
(Wiench et al., 2011).
High-throughput genome-wide approaches have made
enhancer discovery a more amendable task. To date, most of these
studies have been performed on cell lines but the ﬁrst attempts
to follow enhancer dynamics during development have been suc-
cessful (Bogdanovic et al., 2012; Cotney et al., 2012). Given the
spatial and temporal speciﬁcity of enhancers the major challenge
for the future will lie in obtaining the proper tissues at the right
developmental stage or state of differentiation and performing
reliable ChIP-seq on the often limiting amounts of these cells
(Bonn et al., 2012).
TRANSCRIPTION FACTOR-MEDIATED LONG-RANGE
ENHANCER–PROMOTER COMMUNICATION
One key feature of eukaryotic enhancers is that they can be located
far away from the gene they regulate. How enhancers are able
to communicate with their cognate promoters remained a mys-
tery for about two decades. A number of models were proposed
which included polymerase tracking, the spreading of chromatin
structures, and direct contact between separated elements. The
non-contact model (polymerase tracking and chromatin spread-
ing) postulated a role for the intervening chromatin ﬁber which
would propagate a “signal” from the enhancer to the promoter.
The contact model, better known as the looping model, proposed
that the active enhancer and promoter would reside in close prox-
imity within the nucleus while the intervening chromatin loops
out. Although early in vitro experiments in prokaryotic systems
provided support for the contact model [reviewed in Amouyal
(1991)], the ﬁrst direct in vivo evidence in eukaryotes was pro-
vided by the phenomenon of transvection in Drosophila (Tartof
and Henikoff, 1991). The contact model was subsequently exper-
imentally tested by varying the position or distance of genes in a
series of experiments using thehumanβ-globin locus (Hanscombe
et al., 1991; Dillon et al., 1997).
The subsequent development of new techniques like RNA
TRAP (Carter et al., 2002) and chromosome conformation cap-
ture (3C;Dekker et al., 2002) and its application tomammalian loci
(Tolhuis et al., 2002) allowed the mapping of chromatin folding of
gene loci. These studies on the β-globin locus clearly demonstrated
that the major regulatory element of the β-globin genes, the locus
control region (LCR), resides in close proximity to the genes when
active while the intervening chromatin and inactive genes loop
out (Carter et al., 2002; Tolhuis et al., 2002). These interactions
are developmental stage-speciﬁc (Palstra et al., 2003) and depen-
dent on lineage-speciﬁc transcription factors (Drissen et al., 2004;
Vakoc et al., 2005). Chromatin conformations similar to the ones
Frontiers in Genetics | Epigenomics September 2012 | Volume 3 | Article 195 | 2
“fgene-03-00195” — 2012/9/27 — 21:42 — page 3 — #3
Palstra and Grosveld Transcription factor binding at enhancers
initially observed within the β-globin locus have been found in
several other gene loci in different cell types generally conﬁrming
the looping model (de Wit and de Laat, 2012).
3C and its derivatives are currently the method of choice
to demonstrate interactions between enhancers and their tar-
get genes (de Wit and de Laat, 2012). A major limitation of
3C is the fact that some knowledge of the location of the reg-
ulatory elements is needed to design primers. Combining 3C
with high-throughput sequencing allows for the unbiased dis-
covery of novel long-range interactions of a speciﬁc locus (Soler
et al., 2010), especially when combined with ChIP-derived chro-
matin modiﬁcations or transcription factor binding proﬁles as
was demonstrated in a study that identiﬁed adipocyte-speciﬁc
enhancers (Mikkelsen et al., 2010) and a study which identiﬁed
erythroid-speciﬁc enhancers for theMYB gene (Stadhouders et al.,
2011). One of the remaining drawbacks of this approach is that it
still relies on a single locus for a viewpoint and is therefore not truly
unbiased. A Chia-PET approach that focuses on either enhancer
marks (Chepelev et al., 2012) or promoter-associated RNA poly-
merase II (RNA pol II; Li et al., 2012) in part circumvents this
limitation. A truly unbiased method like Hi-C could in princi-
ple detect all long-range enhancer–promoter interactions in a cell
population although limitations in sequencing depth and limita-
tions of the bioinformatic tools available currently restricts the
resolution of this approach (Lieberman-Aiden et al., 2009). How-
ever, taking the fast developments in high-throughput sequencing
and bioinformatics analysis into account it may be in the not too
distant future that enhancer–promoter interactions are routinely
identiﬁed using Hi-C. In fact, a ﬁrst glimpse of tissue-speciﬁc
promoter–enhancer interactions has been observed in a recent
Hi-C study (Dixon et al., 2012).
Binding of lineage-speciﬁc transcription factors to enhancers
and promoters plays a vital role in the establishment/maintenance
of long-range promoter–enhancer interactions. There appears to
be a distinct set of transcription factors that tend to bind to
promoters and a distinct set that tend to bind at distal regula-
tory elements (Lan et al., 2012). Analysis of Hi-C and ENCODE
data obtained in erythroid leukemia cells indicated that in gen-
eral factors bound at promoters interact with factors bound at
distal sites (Lan et al., 2012). For some transcription factors their
role in chromatin looping has been studied in more detail. In
a knock-out mouse model of the erythroid-speciﬁc transcription
factor EKLF, no long-range interactions between the β-globin LCR
and β-major gene are observed and the β-globin locus adopts a
chromatin conformation reminiscent of the one observed in ery-
throid progenitor cells (Drissen et al., 2004). Re-introduction of
EKLF restores LCR–β-globin interaction and this also occurs in the
absence of protein synthesis demonstrating a direct involvement of
EKLF in chromatin looping (Drissen et al., 2004). A similar study
on the transcription factors GATA-1 and FOG1 has shown that
these factors also play a vital role in LCR–β-globin gene interaction
(Vakoc et al., 2005). The role of another erythroid transcription
factor, the heterodimeric NF-E2 has beenmore controversial. One
study demonstrated that chromatin looping was independent of
NF-E2 in a knock-out mouse model of the NF-E2 p45 subunit
(Kooren et al., 2007) while an other study demonstrated NF-E2-
dependent chromatin looping in a cellular model system upon
knock down of the MafK/NF-E2 p18 subunit (Du et al., 2008).
Other lineage-speciﬁc factors that have been shown to play a role
in chromatin looping are GATA3 and STAT6 in the T-cell lineage
(Spilianakis and Flavell, 2004) and OCA-B in the B-cell lineage
(Ren et al., 2011).
It is doubtful that lineage-speciﬁc DNA binding transcription
factors are solely responsible for establishing enhancer–promoter
interactions. Enhancer bound transcription factors recruit co-
activators and general factors of which some have been shown
to play a vital role in enhancer–promoter communication. One
of the best studied factors is the widely expressed transcriptional
cofactor Ldb1. The non-DNA-binding Ldb1 protein is able to
interact with multiple transcription factors and mediates interac-
tions between them (Matthews and Visvader, 2003). In erythroid
cells, Ldb1 is part of a large complex that contains the core fac-
tors TAL1, LMO2, E2A, and GATA1 which is recruited to E boxes
and GATA elements in, for example, the β-globin LCR and pro-
moter (Wadman et al., 1997; Soler et al., 2010). Knock-down of
Ldb1 in erythroid cells results in an impaired long-range inter-
action between the β-globin LCR and β-major promoter and a
failure to activate β-major expression (Song et al., 2007). A recent
report demonstrated that artiﬁcial tethering of the self associa-
tion domain of Ldb1 to the β-globin promoter is able to induce
a chromatin loop between the β-globin LCR and promoter and
this was sufﬁcient to induce expression of the β-globin gene
(Deng et al., 2012b). Other general factors implicated in chro-
matin loop formation between enhancers and promoters are Brg1,
the ATPase component of the SWI/SNF nucleosome remodeling
complex (Kim et al., 2009) and the general transcription factor
TFII-I (Ren et al., 2011). A different type but very interesting gen-
eral nuclear factor involved in chromatin looping is cohesin. It
is best known for its role in holding together sister chromatids
during mitosis, but more recently it has been recognized that
cohesin is intimately linked to transcription (Dorsett, 2011; Haer-
ing and Jessberger, 2012). The nuclear protein CCCTC-binding
factor (CTCF) is thought to partition the genome in separate
domains via chromatin loops preventing crosstalk between active
and inactive regions (Weth and Renkawitz, 2011; Herold et al.,
2012). Recently it was found that these CTCF-mediated chro-
matin loops are dependent on cohesin (Parelho et al., 2008; Rubio
et al., 2008; Wendt et al., 2008; Wendt and Peters, 2009). Inter-
estingly, in murine ES cells cohesin interacts with Mediator and
the cohesin loading factor Nipbl and together they participate
in chromatin loop formation between enhancers and promot-
ers of ES cell-speciﬁc loci (Kagey et al., 2010). Similarly, upon
differentiation of mouse erythroid leukemia (MEL) cells cohesin
and Nipbl are recruited to the β-globin LCR and β-major pro-
moter coinciding with an increase in transcription. Knock-down
of one of these factors resulted in reduced chromatin looping
between the β-globin LCR and promoter (Chien et al., 2012).
Furthermore, the TBP core promoter associated factor TAF3 coop-
erates with CTCF and cohesin to mediate long-range chromatin
loops between enhancers and promoters in the endoderm lineage
(Liu et al., 2011).
The general picture that is emerging from these studies is
that lineage-speciﬁc DNA binding transcription factors bound at
promoters and enhancers recruit “looping” factors which setup
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contacts between distal enhancers and promoters. Such factors
appear to form loops within more “structural” loops mediated by
general factors like CTCF (Figure 1).
The fact that active enhancers reside within close proximity of
the active promoters they regulate is currently well recognized.
How these interactions are established remains largely unknown.
Whether the formation of a chromatin loop is an actively directed
process or determined by random collisions has not been elu-
cidated. Several studies suggest that polymerization of nuclear
actin might be a driving force in bringing enhancers and promot-
ers together. For example, actin polymerization is necessary for
retonic acid induced recruitment of transcription factors to an
enhancer element, for the induction of HoxB transcription (Ferrai
et al., 2009), for the reactivation of OCT4 during reprogramming
by oocytes (Miyamoto et al., 2012), and for the re-localization of
gene loci in the interphase nucleus (Chuang et al., 2006; Dundr
et al., 2007). Additionally, motor-proteins like nuclear Myosin I
and dynein light chain-I have also been reported to be essen-
tial for nuclear receptor-induced co-localization of gene loci (Hu
et al., 2008). The direct involvement of these factors in establish-
ing enhancer–promoter chromatin loops has however not been
shown. Some interpretations of the popular transcription fac-
tory hypothesis suggest an alternative actively directed process
for bringing enhancers and promoters together (Papantonis and
Cook, 2010; Deng et al., 2012a). In this view polymerases bound
to enhancers would real-in the chromatin ﬁber until a promoter is
encountered which is subsequently activated (West and Fraser,
2005). However, promoter–enhancer chromatin loops remain
when RNA pol II transcription is pharmacologically inhibited,
suggesting that such a scenario is unlikely (Mitchell and Fraser,
2008; Palstra et al., 2008).
ENHANCER MODE OF ACTION
How enhancers actually promote transcription of a gene when
in close proximity remains poorly understood. What is clear is
that enhancer bound transcription factors recruit co-activators
either as part of an enhanceosome or ﬂexible billboards (Alvarez
et al., 2003; Arnosti and Kulkarni, 2005). In an enhanceosome
a multiprotein complex is assembled at the enhancer and spac-
ing of transcription factor binding sites is crucial for its function
(Thanos and Maniatis, 1995). A similar model has been suggested
for the multi-enhancer β-globin LCR where the hypersensitive
FIGURE 1 |The genome is organized in transcription factor mediated
chromosome loops. Structural transcription factors like CTCF and cohesin
(green rectangles and black ring) co-operate to partition the genome in
looped domains. Depending on the location of the anchor points of these
looped domains, enhancers are either excluded from a target gene’s
domain, effectively blocking activation (top right), or included in the target
gene’s topological domain (bottom). Tissue speciﬁc and ubiquitous
transcription factors (pentagons) either induce enhancer–promoter
communication via a chromatin loop (bottom right) or keep enhancers
in a silent/poised state (bottom left). Rectangles depict CTCF, the
black ring represents the cohesin complex, pentagons depict enhancer
bound transcription factors and ovals depict components of the
pre-initiation complex. Size of the icons depicts strength of binding or
activity.
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sites of the LCR are thought to form a holo complex (Ellis et al.,
1996; Milot et al., 1996). Billboard enhancers are more ﬂexible
in their architecture since they consist of separate elements that
individually are able to modulate transcription and the additive
repressive or activating effects of these elements would determine
the transcriptional outcome (Arnosti and Kulkarni, 2005).
Traditionally enhancers are thought to enhance recruitment
of RNA pol II and the pre-initiation complex to promoters. It
has been suggested that enhancers (or LCRs) function by sim-
ply increasing the local concentration of transcription factors,
which in turn increases the efﬁciency of transcription (Palstra
et al., 2003). Recent studies have shown that many genes contain
stalled polymerases and that the transition from initiation to elon-
gation appears to be a rate limiting step under stringent control
(Nechaev andAdelman, 2011). It has therefore been suggested that
enhancers play a role in facilitating this transition. Indeed, deletion
of the β-globin LCR results in severely reduced phosphorylation
of the RNA pol II C-terminal domain (CTD) and transcriptional
elongation while pre-initiation complex (PIC) assembly and RNA
pol II recruitment to the β-globin promoter was only reduced
twofold (Sawado et al., 2003). The erythroid Myb gene enhancers
are looped to a conserved CTCF binding site in the ﬁrst intron
of the Myb gene. The p-TEFb component Cdk9 is speciﬁcally
recruited to the enhancer as part of the Ldb1 complex, and the
conserved CTCF site in the intron marks a transition between
pausing and elongating polymerases suggesting that enhancers are
also essential in regulating transcriptional elongation (Stadhoud-
ers et al., 2011). Other results were obtained in a recent study were
chromatin looping between the β-globin LCR and β-major gene
was induced by tethering of a looping factor (Deng et al., 2012b).
Recruitment of RNA pol II to the β-major promoter was restored
upon induced chromatin looping while transcriptional elonga-
tion remained reduced. The lack of transcriptional elongation is
in part explained by the failure to recruit and activate the P-TEFb
elongation factor in this system which lacks the crucial erythroid-
speciﬁc transcription factor GATA1 (Deng et al., 2012b). Together,
these studies suggest that enhancers have a function in both PIC
and RNA pol II recruitment or stabilization and facilitation of the
transition between initiation and elongation.
Alternative mechanisms for enhancer function have also been
proposed. Recent genome-wide studies have made clear that RNA
pol II is recruited to enhancers (De Santa et al., 2010; Kim et al.,
2010; Koch et al., 2011) and that these enhancers are transcribed
(Melgar et al., 2011;Wang et al., 2011). A role for these transcripts
in enhancer function has been suggested (Orom and Shiekhattar,
2011), however their exact role remains uncertain. Although some
non-coding (nc) RNAs seem to behave like classical enhancers
in reporter assays (Orom et al., 2010), other observations seem to
refute a direct role for the generatedncRNA transcript. The activity
of the human growth hormone enhancer is for example dependent
on the level of enhancer transcription but not on the structure of
its ncRNA (Yoo et al., 2012). Another example where non-coding
transcripts are linked to enhancer function is the Kcnq1 imprinted
domain (Korostowski et al., 2011). In this case, chromatin loop
formation between regulatory elements prevents Kcnq1 promoter
silencing by the non-coding Kcnq1ot1 transcript. An attractive
but as yet untested possibility is that the ncRNAs are involved
in promoting/stabilizing the interaction between the enhancer
and its target promoter by RNA binding transcription factors at
the enhancer and basic complex transcription factors at the pro-
moter. The observation that RNA pol II complexes are recruited
to enhancers has lead to a model in which enhancers are able to
transfer RNA pol II to promoters either via direct transfer (Leach
et al., 2001) or a tracking mechanism (Zhu et al., 2007). Transfer
of polymerases from enhancer sequences to promoter sequences
was indeed demonstrated in an in vitro assay (Vieira et al., 2004).
Convincing in vivo data to support this model are however lacking
and RNA pol II is still recruited to the β-major gene in the absence
of an LCR (Sawado et al., 2003).
Enhancers also seem to play a role in polycomb eviction from
developmental promoters containing CpG islands by recruit-
ing the histone H3K27me3 demethylase JMJD3 to the promoter
(Taberlay et al., 2011; Vernimmen et al., 2011). In fact, the activity
of developmental enhancers itself appears to be kept under tight
control by members of the polycomb complex and several other
histonemethyl transferases (Svotelis et al., 2011;Whyte et al., 2012;
Zhu et al., 2012). In breast cancer cells, the poised enhancer of Bcl-
2 is marked by H3K27me3. Activation of this enhancer requires
the inactivation of the H3K27 methylase EZH2 a member of the
polycomb complex and the simultaneous recruitment of the his-
tone H3K27me3 demethylase JMJD3 which is under hormonal
control (Svotelis et al., 2011). Several enhancers that have ubiq-
uitous activities when tested in transgenic assays are repressed in
non-permissive cells by the presence of ﬂanking regions enriched
in H3K9me3 at their endogenous location (Zhu et al., 2012).
Cell type-speciﬁc recruitment of the H3K9 demethylase Jmjd2d
alleviates this repression. Conversely, enhancers responsible for
maintaining ES cell identity have to be silenced upon differen-
tiation, which occurs through the recruitment of the H3K4/K9
histone demethylase LSD1 (Whyte et al., 2012).
On the other hand, enhancers that have to become active
in a speciﬁc lineage are kept in a poised state upon stem cell
differentiation via the sequential recruitment of lineage-restricted
transcription factors. The transcription factor SOX2 is for exam-
ple bound at neuron-speciﬁc regulatory elements in embryonic
stem cells, and is replaced by SOX3 in neuronal progenitor cells
and later by SOX11 in terminal differentiated neurons (Bergsland
et al., 2011).
It is very well possible that enhancer action goes beyond just
one activity and that enhancers perform different tasks sequen-
tially during cellular differentiation. Initially, enhancers will keep
gene loci in a transcriptionally competent state by sequential
recruitment of progressively more lineage-restricted transcription
factors. At a later stage, they will assemble and stabilize a pre-
initiation complex at the gene promoter via chromatin looping
and ﬁnally release paused polymerases through recruitment of
elongation factors.
SPLIT PERSONALITIES OF REGULATORY ELEMENTS
As mentioned before, eukaryotic enhancers were operationally
deﬁned in transient transfection assays by the ability to activate
a reporter gene irrespective of location and orientation relative to
the promoter. This does not necessarily mean that these regula-
tory elements behave in a similar fashion at their native location
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in the chromatin context of a cell which is subject to a variety
of external signaling cues. The activity of enhancer like elements
is regulated in a strict temporal and positional manner within a
developing organism. A better approach to test the enhancer like
abilities of a DNA sequence is to test it linked to a reporter gene via
a transgenic approach. Besides the fact that enhancers can switch
between multiple active, poised, and repressed states (Creyghton
et al., 2010; Rada-Iglesias et al., 2011; Zentner et al., 2011), new
studies indicate that a cis-regulatory element can have multiple
properties simultaneously.
Depending on the assays used, multiple distinct classes of
cis-regulatory elements can be recognized (Raab and Kamakaka,
2010). Promoters are bound by transcription factors, provide
an assembly point for the RNA pol II holo complex and gener-
ally designate a more or less deﬁned directional starting point of
transcription. Enhancers recruit transcription factors, they can
be transcribed and are able to boost expression from a distally
located promoter often in a developmental stage and tissue-
restricted manner. The action of enhancers can be counteracted
by enhancer blockers when placed between the enhancer and
promoter. On the other hand, silencers can suppress transcrip-
tion from multiple positions relative to enhancers and promoters.
Finally, insulators are genetic elements that counteract the spread
of heterochromatin.
As discussed above genome-wide studies have demonstrated
that many enhancers recruit RNA pol II and are transcribed (De
Santa et al., 2010; Kim et al., 2010). Similar observations have
been made almost two decades ago for hypersensitive site 2 of
the β-globin LCR (Tuan et al., 1992). Most of these enhancer
transcripts can be polyadenylated but remain short and are not
elongated (Kim et al., 2010). Enhancers that are located intragenic
however produce long spliced and polyadenylated transcripts and
may therefore function as alternative promoters (Kowalczyk et al.,
2012). Promoters of tRNA genes on the other hand have been
shown to act as either insulators or enhancer blocking elements
in yeast (Simms et al., 2008) and mammalian systems (Raab et al.,
2011), which is mediated by binding of the general RNA Pol III
transcription factor TFIIIC. In Drosophila, RNA pol II promot-
ers containing stalled RNA pol II also act as enhancer blocking
elements (Chopra et al., 2009). One model for enhancer block-
ing function, the decoy model, postulates that enhancer blockers
interfere with enhancer–promoter interaction by producing inac-
tive interactions between the enhancer blocking element and the
promoter or the enhancer. Drosophila enhancer blocking ele-
ments indeed appear to form chromatin loops with promoters
(Erokhin et al., 2011). Some enhancer blockers can also act as
silencers in transient transfection assays suggesting that the dis-
tinction between these two elements depends on the assay involved
(Petrykowska et al., 2008). Interestingly, it has been reported that
the β-globin LCR, which is normally a very strong enhancer in
erythroid cells, is able to act as a repressor when placed in the right
genomic context (Feng et al., 2005). Speciﬁc repressors appear
to act on enhancers by interfering with loop formation between
enhancers and gene promoters (Chopra et al., 2012). Replace-
ment of an activating loop by a repressive loop has also been
observed. When the c-Kit gene is active in immature erythroid
cells a GATA2-dependent chromatin loop is present between an
upstream enhancer and the promoter (Jing et al., 2008). Upon
erythroid maturation, GATA1 replaces GATA2 and the activat-
ing enhancer–promoter chromatin loop is replaced by a repressive
chromatin loop between the promoter and a downstream silencer-
like element. Interestingly, several genetic studies in drosophila
have shown that enhancer blockers, when placed in the right con-
text, can enhance enhancer–promoter communication or even act
as enhancer elements (Rodin et al., 2007; Maksimenko et al., 2008;
Soshnev et al., 2008; Fujioka et al., 2009). These observations indi-
cate that enhancer blockers/silencers function, like enhancers, by
means of long-range chromatin interactions. In mammalians, the
major protein associated with enhancer blocking function is the
11 zinc-ﬁnger transcription factor CTCF (Bell et al., 1999), which
is known to mediate long-range chromatin interactions (Splinter
et al., 2006). AlthoughCTCF ismost famous for its role in enhancer
blocking, the protein is also involved in gene activation (Weth
and Renkawitz, 2011; Herold et al., 2012). Recent genome-wide
analysis of enhancer–promoter interactions have indeed indi-
cated that CTCF is associated with a proportion of enhancers
and that CTCF mediates the interaction of these enhancers with
their target promoters (Handoko et al., 2011; Li et al., 2012;
Taslim et al., 2012).
In summary, it seems that the attempt to impose a strict def-
inition on regulatory elements is much more complicated than
expected: enhancers can behave like promoters, promoters can
act as enhancer blockers, while enhancer blockers can function as
enhancers, all dependent on the genomic context of the regulatory
element and the speciﬁc set of transcription factors recruited.
ENHANCER TRANSCRIPTION FACTOR BINDING IN
DEVELOPMENT, DISEASE, AND PHENOTYPE DIVERSITY
Tight control of transcription is crucial for the proper develop-
ment of a multi-cellular organism. Enhancers play a crucial role
in ensuring the proper spatio-temporal expression of genes by
integrating the action of tissue-speciﬁc transcription factors and
signaling cues (Buecker and Wysocka, 2012; Ong and Corces,
2012). Given the key role that enhancers play in the proper
development of multi-cellular organisms it is of no surprise that
disruption of enhancer function is a major contributor to patho-
logical states. In fact, disease driven research has been crucial in the
discovery and deﬁnition of mammalian enhancers. Investigation
of γβ-thalassemia for example led to the discovery and charac-
terization of the “super enhancer”-like β-globin LCR (Grosveld
et al., 1987). In Dutch γβ-thalassemia, a large deletion removes
100 kb upstream of the β-globin gene but leaves the β-globin gene
itself intact (Kioussis et al., 1983; Wright et al., 1984; Taramelli
et al., 1986). The mutant locus is in a closed chromatin state
and suffers from position effects. Further analysis of the region
deleted in γβ-thalassemia revealed strong erythroid hypersensitive
sites upstream of the ε-globin gene (Tuan et al., 1985). Cloning
of these hypersensitive sites revealed that they impose position-
independent, copy number-dependent high level expression on a
β-globin transgene deﬁning the operational properties of a LCR
(Grosveld et al., 1987). Many other instances of disease causing
enhancer disruptions are currently known (Kleinjan and Lettice,
2008). Translocations can either remove enhancer sequences from
a locus (Kioussis et al., 1983) or place ectopic enhancers in the
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vicinity of onco-genes as is observed in non-Hodgkin’s lymphoma
(Hayday et al., 1984). Smallermutations in regulatory elements are
also known to contribute to hereditary disease states. For exam-
ple, several point mutations as well as insertions within the sonic
hedgehog ZRS long-range enhancers cause several forms of preax-
ial polydactyly (Albuisson et al., 2011; Laurell et al., 2012). The
effects of sequence variation in enhancer regions are not always
catastrophic and can be quite subtle.
In the past decade, genome-wide association studies (GWAS)
have identiﬁed many single nucleotide polymorphisms (SNPs)
which are statistically associatedwith phenotypic traits and disease
states. Themajority of the DNA variants identiﬁed in GWAS stud-
ies are located in non-coding regions without any known function
while only a minority (∼30%) potentially disrupt the function
of genes (Visel et al., 2009b; 1000 Genomes Project Consortium,
2010). Often linkage with unknown causal (non-synonymous
coding) DNA variants within a haplotype block is assumed to
explain association of non-coding DNA variants with a given trait.
Howevermeta-analysis demonstrated that 40%of the disease asso-
ciated SNPs including their haplotype blocks exclusively involve
non-coding sequence (Visel et al., 2009b) suggesting that these
regions have a regulatory function. Moreover, a signiﬁcant pro-
portion of GWAS SNPs overlap with B, T, and ES cell enhancers
(Teng et al., 2011),multiple sclerosis associated regions are located
in chromatin regions that are active in B-cells (Disanto et al., 2012)
and 80% of the colorectal cancer risk SNPs overlap with colon
crypt enhancer marks (Akhtar-Zaidi et al., 2012).
One can easily imagine that the presence of a SNP might
lead to differences in transcription factor binding at regulatory
regions which could result in phenotypic changes and even dis-
ease (e.g., cancer) due to differences in transcriptional output of
the associated genes (Figure 2). A study on 10 human lymphoblas-
tic cell lines from different individuals indeed demonstrated that
7.5% of the binding sites for NF-κB and 25% of the RNA pol II
binding sites differed between individuals (Kasowski et al., 2010).
Differential binding occurred frequently at SNPs and structural
variants and was often associated with changes in gene expres-
sion. Measurement of the genome-wide allelic imbalance of 24
transcription factors and the transcriptional co-factor p300 indi-
cated that 5% of the binding sites for these factors vary depending
on the sequence difference between alleles (Reddy et al., 2012).
Chromatin accessibility to DNaseI also depends on genomic vari-
ation in lymphoblastoid cell lines and these differences in DNaseI
hypersensitivity correlate with differences in transcription fac-
tor binding and changes in gene expression (Degner et al., 2012).
These observations strongly suggest that many non-coding DNA
variants are functional andmark for example enhancers for distally
located genes which are involved in the trait under study. Identify-
ing exactly which non-coding SNPs have a regulatory function has
been cumbersome, mainly due to the presence of multiple linked
non-coding SNPswithin a haplotype block, the fact that enhancers
are highly tissue- and developmental stage-speciﬁc and the lack of
proper high-throughput assays to identify enhancer regions. Sub-
sequent identiﬁcation of the genes regulated by the causative SNPs
FIGURE 2 | Model depicting how sequence variation in distal regulatory
elements might influence phenotypes or disease states. A phenotype
associated SNP rsXXXXX is located in an enhancer for gene X. TheT allele of
rsXXXXX binds a transcription factor (the gray pentagon) with high afﬁnity
which allows for chromatin loop formation and proper activation of gene X
resulting in normal development (left, green arrows). The C allele of rsXXXXX
binds the transcription factor with a reduced afﬁnity (light gray pentagon with
dashed border) which leads to a less efﬁcient enhancer, absence/reduction of
looping and diminished expression of gene X resulting in aberrant or deviated
development (right, red arrows). Note that geneY is located in between the
enhancer and gene X and is not regulated by the enhancer. Pentagons
depict enhancer bound transcription factors and ovals depict components of
the pre-initiation complex. Size of the icons depicts strength of binding or
activity.
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has proven to be even more difﬁcult, since enhancers and their
target genes are often separated by a signiﬁcant extent of chro-
matin which can even contain non-target genes. The successful
identiﬁcation of regulatory SNPs and their linked target genes has
therefore been limited to few isolated examples.
Several studies on speciﬁc risk loci support the notion that in
several pathological states SNPs disrupt transcription factor bind-
ing sites within enhancers. For example, a risk allele for cleft lip
disrupts an AP-2α binding site in an IRF6 enhancer (Rahimov
et al., 2008) and a variant linked to plasma low-density lipoprotein
cholesterol and myocardial infarction creates a C/EBPα bind-
ing site which results in altered expression of the SORT1 gene
in hepatocytes (Musunuru et al., 2010). Studies on other dis-
ease associated loci have demonstrated chromatin loops between
the regulatory variant and the genes they regulate. The variant
rs6983267 is associated with an increased risk to develop vari-
ous types of cancers and several studies have demonstrated that
this SNP leads to altered TCF7L2 transcription factor binding,
altered enhancer activity and that this region loops to the MYC
proto-oncogene (Pomerantz et al., 2009; Ahmadiyeh et al., 2010;
Wright et al., 2010). Similar observations have been made for
e.g., variants associated with coronary artery disease (Harismendy
et al., 2011), prostate cancer (Zhang et al., 2012), and COPD
(Zhou et al., 2012). Not al disruptions of enhancers by SNPs
lead to increased disease susceptibility, as they can also have non-
pathological effects leading to phenotypic differences. Recently we
could demonstrate that rs12913832, a SNP strongly associated
with pigmentation in melanocytes, results in differential tran-
scription factor binding at a melanocyte-speciﬁc enhancer. This
difference in transcription factor binding leads to allele depen-
dent attenuated looping between the enhancer and its target the
OCA2 pigment gene (Visser et al., 2012). Interestingly, allelic dif-
ferences in enhancer activity are not always reﬂected in differential
enhancer–promoter interactions (Wright et al., 2010), suggesting
separatemechanisms for chromatin-loop formation and enhancer
activity.
Combining genome-wide ChIP, FAIRE, and 3C high-
throughput approaches with data derived from GWAS studies
promises to boost the discovery of regulatory SNPs. These kinds of
studies are crucial to obtain greater understanding of the impact of
sequence variations on human health and disease (Chorley et al.,
2008; Hawkins et al., 2010; Ernst et al., 2011) or (part of) the
normal variation between individuals. Using these genome-wide
approaches it will be possible to shift from just describing statisti-
cal associations between variants and traits to studies that actually
discover the biology behind disease and phenotype associated
non-coding variants.
CONCLUSIONS AND FUTURE PROSPECTS
Knowledge regarding enhancers and enhancer function has
exploded in the past decades. Much of the early insight into
enhancer function has been obtained from painstakingly dissect-
ing single model loci. Due to the limited amount of loci inves-
tigated, the generality of the occurrence of enhancers and their
mode of action remained unclear. With the recent advent of high
throughput genome-wide techniques we are now able to address
the generality of these early observations. Important insights
regarding enhancer–promoter communication, the occurrence of
enhancers and enhancer function have been obtained. Surpris-
ingly, the regulatory landscape is far more complex and dynamic
as anticipated and it appears that each cell type has thousands of
enhancers of which many are cell type-speciﬁc. Chromatin loop-
ing between regulatory elements is widely observed and appears
to be a general principle for long-range enhancer–promoter
communication.
However, many challenges remain. Little is known about
enhancer dynamics during cellular differentiation, how signaling
cascades impact on enhancer function, the role of enhancers in
evolution and disease susceptibility and how enhancers actually
boost transcription. Further reﬁnement of genome-wide tech-
niques to study enhancer function will help to answer some
of these questions. Tracking transcription factor binding and
chromatin looping during differentiation will provide unprece-
dented insights into the dynamics of enhancer action. Although
genome-wide approaches are currently in vogue to investigate
enhancer function, answers to some of the remaining ques-
tions will still require the careful molecular dissection of selected
model loci.
Even though progress in technologies has been impressive,
several limitations remain. ChIP assays require knowledge regard-
ing the factors involved in the regulation of gene loci and good
quality antibodies against these factors are not always available.
The genome-wide 3C spin offs currently lack resolution, which
hampers the accurate determination of the exact contact points
mediating enhancer–gene interactions. Furthermore, these meth-
ods all depend on protein–protein and protein–DNAcross-linking
using formaldehyde requiring a certain amount of time, setting a
limit on the temporal resolution of these methods. Information
regarding cell-to-cell variability is still lacking, because the major-
ity of the current methods to study enhancer function involve
batch assays on many cells. Therefore, the ﬁeld would greatly ben-
eﬁt from the development of single cell assays to study enhancer
function. The integration of genome-wide data with focused, sin-
gle locus data and single cell data will undoubtedly provide us with
new exciting insights into the mechanisms that shape the genomic
regulatory landscape in ﬂux.
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